Asenapine Synthesis via Copper-Catalyzed Ring Closure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for reliable synthetic procedures for the large-scale production of asenapine, a compound with antipsychotic and antidepressant properties, which can be challenging due to existing methods' inefficiencies and limitations in industrial-scale synthesis.
Innovation Solution
A process involving the reaction of an E-stilbene derivative with an azomethine ylide to form a trans-pyrrolidine derivative, followed by intramolecular ring closure using copper salts, provides a stereoselective and efficient route to asenapine, utilizing reagents like N-methoxymethyl-N-trimethylsilylmethyl-N-methylamine and copper(I) chloride in suitable solvents and conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing synthesis methods are used for asenapine production, then the synthesis can be performed with conventional reagents and conditions, but the yield and purity are insufficient for reliable large-scale production
Solution Approach 1:
The patent changes the chemical reaction parameters by using a copper(I) catalyst system with specific ligands (such as N-methoxymethyl-N-trimethylsilylmethyl-N-methylamine) and controlling the reaction conditions (solvent, temperature, stoichiometry) to achieve high-yielding ring closure reactions that produce asenapine with sufficient purity for pharmaceutical production
Solution Approach 2:
The patent introduces copper(I) chloride as an intermediary catalyst that mediates the intramolecular ring closure reaction, enabling the transformation of the styryl intermediate into the final asenapine product with high efficiency and selectivity, thereby improving both yield and reliability
2Productivity
If conventional synthesis routes are used, then the process can be simpler in terms of reagent selection, but the scalability and safety for industrial production are compromised
Solution Approach 1:
The patent optimizes reaction parameters including using copper(I) salts with specific ligands, controlling the molar ratios of reagents, selecting appropriate solvents, and maintaining controlled temperatures to enable safe and scalable industrial production while minimizing harmful side reactions
Solution Approach 2:
The patent employs copper(I) chloride as a catalyst that can be used in small amounts and does not require complex recovery processes, making the process more suitable for large-scale production where catalyst cost and handling safety are important considerations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method ensures high yield and purity of asenapine, allowing for its production as a pharmaceutically acceptable salt, such as the maleate form, with improved safety and scalability, addressing the limitations of previous synthesis methods.
Implementation Method 1
an E-stilbene derivative of Formula II is reacted in a [3+2] dipolar cycloaddition reaction with an in situ generated azomethine ylide to provide a trans-pyrrolidine derivative of Formula III
Implementation Method 2
treatment under conditions which effect an intramolecular ring closure yield the compound of Formula I
Data Source
AI summary
The invention relates to a novel process for the preparation of asenapine, i.e. trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, as well as to novel intermediate products for use in said process.